Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Oncology
Mike Thompson, MD, PhD, FASCO
mtmdphd
[THREAD] #ClinicalTrials Eligibility [Updated Mar 11, 2020] #ctsm Modernizing Eligibility Criteria for Molecularly Driven #ClinicalTrials [7/20/15] - @EdKimMDLCI et al. JCO @ASCO_pubs http://ow.ly/RGEdG metRCC Clinical Trial Participa
Read more
Larry
Larry64450205
#ncyt #novacyt #alnovThread:Many want to know the company's plans at LT, and post-covid.Haven't you understood yet that it's already happening?1/6Based on Tay's thread, also read:https://twitter.com/TaylorQuant/status/132877
Read more
Jackie Achtert
Jackie_Achtert
Are you ready for the best session of the day?! @CMI_Compas @SMDayPHL #CMICompas Ryan Billings, GSK and @JulieAliaga, @CMI_Compas believe that Disney missed the mark with their Welcome Home video.
Read more
John D. Cook
JohnDCook
In clinical studies of X vs Y, there's a lot going on besides the difference between X and Y. There are also numerous effects that are unaccounted for. The difference
Read more
Shrey Srivastava
BlogShrey
#DDDD #4Dpharma's MRx051 trial found "relative increases in cytotoxic cells, CD8+ T cells and other immune subsets associated with anti-tumour activity". A very good start to the long road to
Read more
Natalia Rudiak
nataliarudiak
I'm wondering if a good metaphor for defunding the police is ...medicine.You wouldn't want a family physician treating breast cancer, or a proctologist delivering a baby...But we expect officers to
Read more
Ambulatus
ambulatus
$RAC.AX #asx #oncology #cancer@RaceOncology could be a 2021 #asx 10+ baggerWhy follows in this thread. First watch the strategy video./1https://www.youtube.com/watch?v=J7WKOtMEPnI Bisantrene was shown decades ago to be safe and effective
Read more
Phatsimo L. Lemogang ๐ง๐ผ๐จ๐บ
drlololems
Iโm frustrated waitse. 1) As batswana we take too long to seek medical attention when we notice stuff growing on our bodies 2) Biopsy results take forever to come through,
Read more
Sandip Patel MD
PatelOncology
KEYNOTE-158 study out in Lancet Oncology, Pembrolizumab for TMB>10- most data time date we have seen since FDA approval, key aspects include tumor types studiedhttps://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30445-9/fu
Read more
Kert Viele
KertViele
(1/n) We often see related datasets (multiple vaccine trials, multiple trials exploring the amyloid hypothesis in Alzheimerโs, basket trials in oncology) How do we think about multiple groups of data
Read more
Andy Flies
WildImmunity
Happy to announce that our new paper that developed colorful system to understand immune evasion by transmissible cancers has been published in @ScienceAdvances https://advances.sciencemag.org/content/6/27/eaba5031Hereโs the story behind
Read more
๐ก๐ถ๐ต๐ฎ๐ฟ ๐๐ฒ๐๐ฎ๐ถ ๐ ๐
nihardesai7
#MedTwitter how often do you use ๐๐ซ๐จ๐๐๐ฅ๐๐ข๐ญ๐จ๐ง๐ข๐ง ?A thread on ๐๐ซ๐จ๐๐๐ฅ๐๐ข๐ญ๐จ๐ง๐ข๐ง for those interested #MedEd #MedStudentTwitter #oncology #hematology #tweetorial Procalc
Read more
Vivek Subbiah, MD
VivekSubbiah
1/10 COVID19 & CancerSeveral studies now provide insights into the enigma surrounding the determinants of COVID-19 & cancer A global effort to understand the riddles of COVID-19 and cancer @NatureCancer
Read more
Brian Cox, MD, MAS
Dr_Brian_Cox
Ready for a wild #hemepath #tweetorial? This case blew me away. Lots to unpack, so let's get started:1/50-year-old female. No past medical history. Presents with left neck swelling, leukocytosis (~15),
Read more
Jocelyn J. Fitzgerald, MD, FACOG
jfitzgeraldMD
Inspired by this tweet, I present: how to relate the Ob/Gyn rotation to your medical students interested in other specialties, a thread:https://twitter.com/toxicologist12/status/1361722601576534020 First things first: will you be taking car
Read more
John Barbieri, MD, MBA
DrJohnBarbieri
Interesting study in @JAADjournals with @AMostaghimi finding an inpatient #dermatogy consult service generated only ~$80k/yr in revenue. To be financially viable, will be crucial to capture the significant indirect value
Read more
‹
1
2
3
4
5
6
7
8
9
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree